Literature DB >> 31081948

Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti-PD-1 monoclonal antibody.

G Richtig1,2, E Ramelyte3, L Koch4, H Greinix5, S Ferrone6, R Dummer3, E Richtig4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31081948      PMCID： PMC8697030          DOI： 10.1111/jdv.15675

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  10 in total

Review 1.  "Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy.

Authors:  Federico Garrido; Teresa Cabrera; Natalia Aptsiauri
Journal:  Int J Cancer       Date:  2010-07-15       Impact factor: 7.396

2.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.

Authors:  N J Stam; H Spits; H L Ploegh
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

3.  Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer.

Authors:  Scott Gettinger; Jungmin Choi; Katherine Hastings; Anna Truini; Ila Datar; Ryan Sowell; Anna Wurtz; Weilai Dong; Guoping Cai; Mary Ann Melnick; Victor Y Du; Joseph Schlessinger; Sarah B Goldberg; Anne Chiang; Miguel F Sanmamed; Ignacio Melero; Jackeline Agorreta; Luis M Montuenga; Richard Lifton; Soldano Ferrone; Paula Kavathas; David L Rimm; Susan M Kaech; Kurt Schalper; Roy S Herbst; Katerina Politi
Journal:  Cancer Discov       Date:  2017-10-12       Impact factor: 39.397

4.  Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules.

Authors:  M A Pellegrino; A K Ng; C Russo; S Ferrone
Journal:  Transplantation       Date:  1982-07       Impact factor: 4.939

5.  A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections.

Authors:  Xinhui Wang; Michael Campoli; Hyun Suk Cho; Takeshi Ogino; Nobuyuki Bandoh; Jijia Shen; Soo Young Hur; Toshiro Kageshita; Soldano Ferrone
Journal:  J Immunol Methods       Date:  2005-04-01       Impact factor: 2.303

6.  Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors.

Authors:  Klaus J Busam; Urvi Mujumdar; Amanda J Hummer; Jennifer Nobrega; William G Hawkins; Daniel G Coit; Mary S Brady
Journal:  Am J Surg Pathol       Date:  2004-11       Impact factor: 6.394

Review 7.  Present Yourself! By MHC Class I and MHC Class II Molecules.

Authors:  Kenneth L Rock; Eric Reits; Jacques Neefjes
Journal:  Trends Immunol       Date:  2016-09-07       Impact factor: 16.687

8.  Identification of ALK as a major familial neuroblastoma predisposition gene.

Authors:  Yaël P Mossé; Marci Laudenslager; Luca Longo; Kristina A Cole; Andrew Wood; Edward F Attiyeh; Michael J Laquaglia; Rachel Sennett; Jill E Lynch; Patrizia Perri; Geneviève Laureys; Frank Speleman; Cecilia Kim; Cuiping Hou; Hakon Hakonarson; Ali Torkamani; Nicholas J Schork; Garrett M Brodeur; Gian P Tonini; Eric Rappaport; Marcella Devoto; John M Maris
Journal:  Nature       Date:  2008-08-24       Impact factor: 49.962

9.  Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines.

Authors:  Rosa Méndez; Teresa Rodríguez; Ana Del Campo; Eva Monge; Isabel Maleno; Natalia Aptsiauri; Pilar Jiménez; Susana Pedrinaci; Graham Pawelec; Francisco Ruiz-Cabello; Federico Garrido
Journal:  Cancer Immunol Immunother       Date:  2007-10-13       Impact factor: 6.968

Review 10.  Desmoplastic melanoma associated with an intraepidermal lentiginous lesion: case report and literature review.

Authors:  Cesar de Souza Bastos Junior; Juan Manuel Piñeiro-Maceira; Fernando Manuel Belles de Moraes
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.